Critical Alert: Navigating Formulary Shake-Ups Under the $2,000 Drug Cap
Kathy Heery RN, BA, MS
Positive Aging Productions, RN Writer and Producer
Recent changes in U.S. healthcare policy capped out-of-pocket prescription drug costs for Medicare beneficiaries at $2,000 per year starting in 2025. While this policy aims to make life-saving medications more affordable, it has unintended consequences. Some pharmaceutical companies are responding by taking certain medications off insurance formularies, limiting access to these drugs through standard Medicare plans. This leaves patients scrambling to find affordable alternatives and raises important questions about how to navigate healthcare costs effectively.
What’s Happening with Formulary Changes?
Insurance formularies are lists of medications covered under a prescription drug plan. Drug companies and insurance providers negotiate which medications are included and at what cost. To mitigate the impact of the $2,000 cap on their profits, pharmaceutical companies are removing medications from their formularies or shifting certain medications to higher-cost formulary tiers.
This tactic forces patients to pay for their medications fully out of pocket or switch to alternatives that might not work as well for their condition. For Medicare beneficiaries, it creates a troubling scenario: While their total costs may be capped, they could still face disruptions in care or limited access to the drugs they depend on. So, what to do during this open enrollment period?
Focus on Overall Costs, Not Just Premiums
Many Medicare beneficiaries focus on plans with the lowest premiums, assuming that will save them the most money. However, this strategy backfires when formulary exclusions, higher deductibles, or higher co-pays for non-preferred medications come into play. To truly minimize healthcare expenses, it's essential to evaluate total potential costs, including premiums, deductibles, and out-of-pocket maximums. Here's how:
The Bigger Picture: Advocacy for Systemic Change
This Wack-a-Mole approach of drug pricing, capping pricing is a losing game. Do not expect any realistic or meaningful change this year. It will be complete chaos so stay tuned for the chaos but make changes now before open enrollment for 2025 closes December 7!!!!!!!!!!!